Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2001-11-30
2010-10-12
Wilson, James O (Department: 1624)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
07812169
ABSTRACT:
The invention provides new and useful analogs of 4-amino-thalidomide. These analogs include S(−)-4-amino-thalidomide and R(+)-4-amino-thalidomide. The invention also provides processes for making these analogs. Further, the invention provides methods for inhibiting angiogenesis and treating angiogenesis-associated diseases, including cancer and macular degeneration, by administering these compounds.
REFERENCES:
patent: 2830991 (1958-04-01), Keller et al.
patent: 3536809 (1970-10-01), Applezweig
patent: 3560495 (1971-02-01), Frankus et al.
patent: 3563986 (1971-02-01), Frankus et al.
patent: 3598123 (1971-08-01), Zaffaroni et al.
patent: 3625946 (1971-12-01), Heinrich et al.
patent: 3705162 (1972-12-01), Graudums et al.
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4008719 (1977-02-01), Theeuwes et al.
patent: 4552888 (1985-11-01), Koppel et al.
patent: 4810643 (1989-03-01), Souza
patent: 4994443 (1991-02-01), Folkman et al.
patent: 4999291 (1991-03-01), Souza
patent: 5001116 (1991-03-01), Folkman et al.
patent: 5021404 (1991-06-01), Folkman et al.
patent: 5059595 (1991-10-01), Le Grazie
patent: 5073543 (1991-12-01), Marshall et al.
patent: 5120548 (1992-06-01), McClelland et al.
patent: 5134127 (1992-07-01), Stella et al.
patent: 5229496 (1993-07-01), Deeley et al.
patent: 5260329 (1993-11-01), Montegilli et al.
patent: 5354556 (1994-10-01), Sparks et al.
patent: 5385901 (1995-01-01), Kaplan et al.
patent: 5391485 (1995-02-01), Deeley et al.
patent: 5393870 (1995-02-01), Deeley et al.
patent: 5399363 (1995-03-01), Liversidge et al.
patent: 5405855 (1995-04-01), Andrulis, Jr.
patent: 5434170 (1995-07-01), Andrulis, Jr.
patent: 5443824 (1995-08-01), Piacquadio
patent: 5502066 (1996-03-01), Heinemann et al.
patent: 5528823 (1996-06-01), Rudy, Jr. et al.
patent: 5580755 (1996-12-01), Souza
patent: 5591767 (1997-01-01), Mohr et al.
patent: 5593990 (1997-01-01), D'Amato
patent: 5605684 (1997-02-01), Piacquadio
patent: 5605914 (1997-02-01), Muller
patent: 5629327 (1997-05-01), D'Amato
patent: 5635517 (1997-06-01), Muller et al.
patent: 5639476 (1997-06-01), Oshlack et al.
patent: 5639725 (1997-06-01), O'Reilly et al.
patent: 5643915 (1997-07-01), Andrulis, Jr. et al.
patent: 5654312 (1997-08-01), Andrulis, Jr. et al.
patent: 5674533 (1997-10-01), Santus et al.
patent: 5679696 (1997-10-01), Fenton et al.
patent: 5698579 (1997-12-01), Muller
patent: 5712291 (1998-01-01), D'Amato
patent: 5731325 (1998-03-01), Andrulis, Jr. et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5733876 (1998-03-01), O'Reilly et al.
patent: 5776704 (1998-07-01), O'Reilly et al.
patent: 5792845 (1998-08-01), O'Reilly et al.
patent: 5798368 (1998-08-01), Muller et al.
patent: 5837682 (1998-11-01), Folkman et al.
patent: 5854205 (1998-12-01), O'Reilly et al.
patent: 5854221 (1998-12-01), Cao et al.
patent: 5861372 (1999-01-01), Folkman et al.
patent: 5874448 (1999-02-01), Muller et al.
patent: 5877200 (1999-03-01), Muller
patent: 5885795 (1999-03-01), O'Reilly et al.
patent: 5929117 (1999-07-01), Muller et al.
patent: 5948403 (1999-09-01), Sone et al.
patent: 5955476 (1999-09-01), Muller et al.
patent: 6020358 (2000-02-01), Muller et al.
patent: 6071948 (2000-06-01), D'Amato
patent: 6114355 (2000-09-01), D'Amato
patent: 6140346 (2000-10-01), Andrulis, Jr. et al.
patent: 6228879 (2001-05-01), Green et al.
patent: 6235756 (2001-05-01), D'Amato
patent: 6281230 (2001-08-01), Muller et al.
patent: 6316471 (2001-11-01), Muller et al.
patent: 6326388 (2001-12-01), Man et al.
patent: 6335349 (2002-01-01), Muller et al.
patent: 6380239 (2002-04-01), Muller et al.
patent: 6395754 (2002-05-01), Muller et al.
patent: 6403613 (2002-06-01), Man et al.
patent: 6420414 (2002-07-01), D'Amato
patent: 6458810 (2002-10-01), Muller et al.
patent: 6469045 (2002-10-01), D'Amato
patent: 6476052 (2002-11-01), Muller et al.
patent: 6518298 (2003-02-01), Green et al.
patent: 6555554 (2003-04-01), Muller et al.
patent: 7153867 (2006-12-01), Shah et al.
patent: 2001/0018445 (2001-08-01), Huang et al.
patent: 2001/0056114 (2001-12-01), D'Amato
patent: 2002/0035090 (2002-03-01), Zeldis et al.
patent: 2002/0045643 (2002-04-01), Muller et al.
patent: 2002/0049231 (2002-04-01), D'Amato
patent: 2002/0052398 (2002-05-01), D'Amato
patent: 2002/0054899 (2002-05-01), Zeldis
patent: 2002/0061923 (2002-05-01), D'Amato
patent: 2002/0082290 (2002-06-01), D'Amato
patent: 2002/0128228 (2002-09-01), Hwu
patent: 2002/0161023 (2002-10-01), D'Amato
patent: 2002/0173658 (2002-11-01), Muller et al.
patent: 2002/0183360 (2002-12-01), Muller et al.
patent: 2003/0013739 (2003-01-01), Masferrer et al.
patent: 2003/0028028 (2003-02-01), Man et al.
patent: 2003/0045552 (2003-03-01), Robarge et al.
patent: 2003/0069428 (2003-04-01), Muller et al.
patent: 2003/0096841 (2003-05-01), Robarge et al.
patent: 2003/0139451 (2003-07-01), Shah et al.
patent: 2003/0144325 (2003-07-01), Muller et al.
patent: 2003/0181428 (2003-09-01), Green et al.
patent: 2003/0187024 (2003-10-01), D'Amato
patent: 2003/0191098 (2003-10-01), D'Amato
patent: 2003/0235909 (2003-12-01), Hariri et al.
patent: 2004/0029832 (2004-02-01), Zeldis
patent: 2004/0077685 (2004-04-01), Figg et al.
patent: 2004/0077686 (2004-04-01), Dannenberg et al.
patent: 2004/0087546 (2004-05-01), Zeldis
patent: 2004/0091455 (2004-05-01), Zeldis
patent: 2004/0122052 (2004-06-01), Muller et al.
patent: 2004/0127545 (2004-07-01), D'Amato et al.
patent: 2004/0220144 (2004-11-01), Zeldis
patent: 2004/0266809 (2004-12-01), Emanuel et al.
patent: 2005/0096351 (2005-05-01), Jaworsky et al.
patent: 2005/0203142 (2005-09-01), Zeldis et al.
patent: 0325199 (1989-07-01), None
patent: 0357061 (1990-03-01), None
patent: 768821 (1957-02-01), None
patent: 58-131978 (1983-08-01), None
patent: 63-119500 (1988-05-01), None
patent: WO 91/10424 (1991-07-01), None
patent: WO 92/14455 (1992-09-01), None
patent: WO 92/18496 (1992-10-01), None
patent: WO 94/20085 (1994-09-01), None
patent: WO 95/04533 (1995-02-01), None
patent: WO 98/03502 (1998-01-01), None
patent: WO 98/54170 (1998-12-01), None
patent: WO 00/55134 (2000-09-01), None
patent: WO 01/70275 (2001-09-01), None
patent: WO 01/87307 (2001-11-01), None
patent: WO 02/059106 (2002-08-01), None
patent: WO 02/064083 (2002-08-01), None
patent: WO 03/086373 (2003-10-01), None
C. Bonzano, European Communication pursuant to Article 96(2) EPC in connection with EP Application No. 01270117.3-1216, dated Jul. 12, 2005.
Polonski, “Circular Dichroism Spectra and Molecular Geometry of Six-Membered Ring Anhydrides and Imides,”J. Chem. Soc., Perkin Trans. 1, 1988, pp. 639-648.
Matsumura et al., “New Reaction Conditions Using Trifluoroethanol for the E-I Hofmann Rearrangement,”J. Chem. Soc., Perkin Trans. 1, 1999, pp. 2057-2060.
Lee et al., “The Effect of N-Substituted Alkyl Groups on Anticonvulsant Activities of N-Cbz-a-amino-N-alkylglutarimides,” Arch. Pharm. Res., vol. 22, No. 5, pp. 491-495 (1999).
U.S. Appl. No. 09/287,377, filed Apr. 7, 1999, D'Amato.
Corral et al., 1999, “Immunomodulation Immunomodulation by thalidomide and thalidomide analogues,” Ann Rheum Dis. Suppl 1:1107-13.
D'Amato et al., 2001, “Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma,” Semin. Oncol. 28:597-601.
He, W. et al., 1993, 206th American Chemical Society, Chicago, IL; Med. Chem., paper 216.
Jonsson, 1972, “Chemical structure and teratogenic properties. 3. A review of available data on structure-activity relationships and mechanism of action of thalidomide analogues,” Acta. Pharm. Suec. 9(6):521-542.
Lentzsch et al., 2002, “S-3-amino-phthalimido-glutarimide inhibits angiogenesis and growth of B-cell neoplasias in mice,” Cancer Research 62:2300-2305.
Muller et al., 1999, “Amino-substituted thalidomide analogs; potent inhibitors of TNF-alpha production,” Bioorg. Med. Chem. Lett. 9(11):1625-1630.
Shah et al., 1999, “Synthesis and enantiomeric separation of 2-phthalimidino-glutaric acid analogues: potent inhibitors of tumo
Conner Barry P.
D'Amato Robert J.
Hunsucker Kimberly A.
Pribdula Victor
Rougas John
Jones Day
Sackey Ebenezer
The Children's Medical Center Corporation
Wilson James O
LandOfFree
Method of synthesis of 4-amino-thalidomide enantiomers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of synthesis of 4-amino-thalidomide enantiomers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of synthesis of 4-amino-thalidomide enantiomers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4219580